TTKHLTCARE2024-10-012024-12-31 TTKHLTCARE2024-10-012024-12-31 TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneOperatingExpenses01Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourOperatingExpenses01Member TTKHLTCARE2024-12-31 TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue01Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue02Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue03Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue04Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue05Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentRevenue06Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue01Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue02Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue03Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue04Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue05Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentRevenue06Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults01Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults02Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults03Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults04Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults05Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentResults06Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults01Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults02Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults03Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults04Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults05Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:FourReportableSegmentResults06Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets01Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets02Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets03Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets04Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets05Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentAssets06Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member TTKHLTCARE2024-12-31in-bse-fin:OneReportableSegmentLiabilities01Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member TTKHLTCARE2024-12-31in-bse-fin:OneReportableSegmentLiabilities02Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member TTKHLTCARE2024-12-31in-bse-fin:OneReportableSegmentLiabilities03Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities04Member TTKHLTCARE2024-12-31in-bse-fin:OneReportableSegmentLiabilities04Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities05Member TTKHLTCARE2024-12-31in-bse-fin:OneReportableSegmentLiabilities05Member TTKHLTCARE2024-10-012024-12-31in-bse-fin:OneReportableSegmentLiabilities06Member TTKHLTCARE2024-12-31in-bse-fin:OneReportableSegmentLiabilities06Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 507747 TTKHLTCARE NOTLISTED TTK Healthcare Limited Equity 2024-04-01 2025-03-31 2025-01-24 2025-01-09 INR Lakhs Third quarter 12:00:00 13:20:00 2025-01-24 2025-01-24 Not applicable Multi segment 2024-10-01 2024-12-31 Unaudited Standalone 2047448000.00 178369000.00 2225817000.00 466589000.00 443213000.00 70505000.00 384263000.00 8233000.00 21108000.00 605971000.00 1999882000.00 225935000.00 0.00 225935000.00 58500000.00 111000.00 58611000.00 0.00 167324000.00 0.00 0.00 0.00 0.00 167324000.00 -9803000.00 157521000.00 0.00 0.00 141303000.00 10 11.84 11.84 0.00 0.00 11.84 11.84 Notes: 1. The above financial results for the Third Quarter and Period ended December 31, 2024 in respect of TTK Healthcare Limited (the Company) have been reviewed by the Audit Committee at its meeting held on January 23, 2025 and approved by the Board of Directors of the Company at its meeting held on January 24, 2025 at the Registered Office of the Company, also with the provision of Video Conferencing facility. 2. The Statutory Auditors of the Company have carried out Limited Review of the above Unaudited Financial Results in terms of Regulations 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3. The Company does not have any Subsidiary / Associate / Joint Venture Company(ies) as on December 31, 2024. 4. During the First Quarter of this financial year, the Company had sold Leasehold land with building at Mahindra World City, Chennai for a consideration of Rs.2,300 lakhs and the profit on sale amounting to Rs.1,977.05 lakhs (Net) has been considered in the above results. 5. Implementation of the Code of Social Security 2020, which is likely to impact the contributions by the Company towards Provident Fund, Gratuity and other related areas has been deferred by the Government beyond April 01, 2021. However, the Company based on the initial assessment made a provision for Rs.350 lakhs in the Fourth Quarter of FY 2020-21 and proposes to take further appropriate action after the Rules are made applicable. 6. The previous period's / year's figures have been regrouped and reclassified, wherever necessary to conform to the current period's / year's presentation. 7. This statement is also available on the website of BSE Limited (www.bseindia.com), National Stock Exchange of India Limited (www.nseindia.com) and also on the website of the Company (www.ttkhealthcare.com). Multi segment 2024-04-01 2024-12-31 Unaudited Standalone 6111338000.00 525662000.00 6637000000.00 1457601000.00 1388375000.00 -31862000.00 1145081000.00 24195000.00 61668000.00 1923889000.00 5968947000.00 668053000.00 197705000.00 865758000.00 211500000.00 -828000.00 210672000.00 0.00 655086000.00 0.00 0.00 0.00 0.00 655086000.00 22283000.00 677369000.00 0.00 0.00 141303000.00 10 46.36 46.36 0.00 0.00 46.36 46.36 Other Expenses 605971000.00 Other Expenses 1923889000.00 ANIMAL WELFARE 328191000.00 CONSUMER PRODUCTS 593672000.00 FOODS 316766000.00 MEDICAL DEVICES 214479000.00 OTHERS 658000.00 PROTECTIVE DEVICES 593682000.00 ANIMAL WELFARE 957695000.00 CONSUMER PRODUCTS 1920167000.00 FOODS 965203000.00 MEDICAL DEVICES 675487000.00 OTHERS 2359000.00 PROTECTIVE DEVICES 1590427000.00 2047448000.00 6111338000.00 2047448000.00 6111338000.00 ANIMAL WELFARE 29754000.00 CONSUMER PRODUCTS 64508000.00 FOODS 14312000.00 MEDICAL DEVICES 52539000.00 OTHERS 806000.00 PROTECTIVE DEVICES -3110000.00 ANIMAL WELFARE 77815000.00 CONSUMER PRODUCTS 205989000.00 FOODS 31693000.00 MEDICAL DEVICES 157240000.00 OTHERS 2460000.00 PROTECTIVE DEVICES -37914000.00 158809000.00 437283000.00 8233000.00 24195000.00 -75359000.00 Notes: 1. Segments have been identified in line with the Indian Accounting Standard on Segment Reporting (Ind AS 108) based on review of performance by the Top Management. 2. Details of products included in each of the Segments are as below : Animal Welfare comprise products for Veterinary use. Consumer Products comprise marketing and distribution of Woodward's Gripewater, EVA Range of Cosmetics, Good Home range of Scrubbers, Air Fresheners, etc. Medical Devices include Artificial Heart Valves, Orthopaedic Implants, etc. Protective Devices comprise manufacturing and marketing of Male Contraceptives and other allied products. Foods comprise manufacturing and marketing of Food Products. Others include Printing and Publishing of Maps and Atlases. 3. The segment wise revenue, results, assets and liabilities figures relate to respective amounts directly identifiable to each of the segments. The unallocable expenditure includes expenses incurred on common services at the corporate level and also those expenses not identifiable to any specific segment. 4. The previous period's / year's figures have been regrouped and reclassified, wherever necessary to conform to the current period's / year's presentation. -452670000.00 225935000.00 865758000.00 ANIMAL WELFARE 400422000.00 CONSUMER PRODUCTS 400219000.00 FOODS 672478000.00 MEDICAL DEVICES 685797000.00 OTHERS 29675000.00 PROTECTIVE DEVICES 1346801000.00 3535392000.00 ANIMAL WELFARE 314478000.00 CONSUMER PRODUCTS 618662000.00 FOODS 152538000.00 MEDICAL DEVICES 159210000.00 OTHERS 14860000.00 PROTECTIVE DEVICES 447614000.00 1707362000.00 412470000.00 2119832000.00 -11527000.00 25555000.00 -1724000.00 3272000.00